REVIVE THERAPEUTICS
Revive Therapeutics Ltd. (TSX-V: RVV) (OTCQB: RVVTF) (FSE: 31R) is focused on the research, development and commercialization of novel therapies and technologies for the medical cannabis and cannabinoid pharmaceuticals markets by identifying and investigating potential therapies targeting the endocannabinoid system, such as cannabinoids, that may be repurposed for new indications, be delivered in a different way, combined with existing drugs, or be developed as new chemical entities.
REVIVE THERAPEUTICS
Industry:
Cannabis Pharmaceutical
Founded:
2012-01-01
Address:
Vaughan, Ontario, Canada
Country:
Canada
Website Url:
http://www.revivethera.com
Total Employee:
1+
Status:
Active
Contact:
905-605-5535
Total Funding:
23 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Apache Wordpress Plugins
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
LivWell Enlightened Health
LivWell Enlightened Health is a medical cannabis company producing and retailing multi-state cannabis.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-11-13 | Greeninsightz | Greeninsightz acquired by Revive Therapeutics | N/A |
Official Site Inspections
http://www.revivethera.com Semrush global rank: 3.68 M Semrush visits lastest month: 3.79 K
- Host name: 129.0.153.160.host.secureserver.net
- IP address: 160.153.0.129
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Revive Therapeutics"
Revive Therapeutics Enters into Agreement with Defence Research …
TORONTO, Oct. 17, 2023 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the …See details»
Revive Therapeutics Provides Corporate Update
TORONTO, March 12, 2024 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the …See details»
Revive Therapeutics Provides Update Evaluating Bucillamine for …
Jan 16, 2024 · DRDC is investigating pharmacological compounds that can mitigate nerve agent induced brain injury. Recent studies have shown that antioxidant compounds such as n …See details»
Revive Therapeutics Ltd. CSE: RVV | USA: RVVTF | LinkedIn
Revive is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take...See details»
Revive Therapeutics - Crunchbase Company Profile & Funding
Revive Therapeutics Ltd. (TSX-V: RVV) (OTCQB: RVVTF) (FSE: 31R) is focused on the research, development and commercialization of novel therapies and technologies for the …See details»
Revive Therapeutics Announces FDA Acceptance of Meeting …
Apr 18, 2024 · Revive is also advancing the development of Psilocybin-based therapeutics through various programs. For more information, visit www.ReviveThera.com.See details»
Revive Therapeutics Ltd. | The Canadian Securities …
Currently, the Company is exploring the use of Bucillamine for the potential treatment of public health medical emergencies and rare inflammatory disorders. Revive is also advancing the development of Psilocybin-based therapeutics …See details»
Revive Therapeutics Provides Update on FDA Type C Meeting for …
TORONTO, June 12, 2024 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the …See details»
Revive Therapeutics Ltd. (RVVTF) - Yahoo Finance Canada
See the company profile for Revive Therapeutics Ltd. (RVVTF) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Revive Therapeutics Provides Update From FDA Meeting for Long …
Jun 10, 2024 · Revive Therapeutics is a life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical …See details»
Revive Therapeutics Provides Update on Research Study
TORONTO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences …See details»
Revive Therapeutics Announces Publication Demonstrating
Nov 12, 2024 · Revive Therapeutics is a life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical …See details»
Revive Therapeutics Enters into Worldwide Exclusive Agreement …
Nov 6, 2023 · Revive Therapeutics and Lawson will work together in completing the development of a qELISA laboratory test kit and a lateral flow assay point of care device for rapid testing of …See details»
Revive Therapeutics Provides Update on Psilocybin Clinical
TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences …See details»
Revive Therapeutics Provides Update on Research Study …
Jul 2, 2024 · Revive is also advancing the development of Psilocybin-based therapeutics through various programs. For more information, visit www.ReviveThera.com. For more information, …See details»
Revive Therapeutics - Overview, News & Similar companies
View Revive Therapeutics (www.revivethera.com) location in Ontario, Canada , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Revive Therapeutics Announces Strategic Focus on Bucillamine for ...
TORONTO, Sept. 18, 2024 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the …See details»
Revive Therapeutics Provides Update on Psilocybin Clinical Study …
Apr 2, 2024 · Revive is also advancing the development of Psilocybin-based therapeutics through various programs. For more information, visit www.ReviveThera.com.See details»
Give Thanks for Your Gifts - Harvest
1 day ago · Harvest Daily Devotion by Pastor Greg Laurie – “Give Thanks for Your Gifts” – God has given you an important spiritual gift.See details»
Revive Therapeutics Submits Type C Meeting Request Package to …
TORONTO, March 27, 2024 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the …See details»